EYA4-deficient mice exhibit severe hearing deficits and develop otitis media with effusion [12], which may resemble the effects of the EYA4 mutations, which cause sensorineural hearing loss accompanied by cardiomyopathy in humans [13–16]. The gene discussed is EYA4; the disease is cardiomyopathy.